AI developer Vista AI has closed on $29.5 million in a Series B financing round.
New investors include Cedars-Sinai Health System, Intermountain Health, the University of Utah Hospital System, Temple University/Fox Chase Cancer Center, and Tampa General Hospital, the company said.
The funds will help accelerate Vista AI's growth, according to the vendor. The company is building on its U.S.-cleared and commercially available cardiac MRI platform by expanding into additional anatomies, including the brain, prostate, and spine, Vista AI said. The company said it is also extending its offerings to remote scanning services to enable sites without prior cardiac MRI expertise or staffing to offer exams to their patients.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
